HCPCS J0713

Injection, ceftazidime, per 500 mg

HCPCS Information

HCPCS Code: J0713
The Healthcare Common Procedure Coding System (HCPCS) is a set of unique alphanumeric codes used to report medical procedures and services to healthcare programs like Medicare and Medicaid. HCPCS codes are used in conjunction with NDC codes for billing and medical documentation puporses. For instance, HCPCS J0713 identifies the type of service or supply used while any of the 22 NDC codes below could be used to specify the exact drug used.
Short Description
Inj ceftazidime per 500 mg
Long Description
Injection, ceftazidime, per 500 mg
Pricing Indicator
Drugs
Multiple Pricing Indicator
Not applicable as HCPCS priced under one methodology
Coverage Description
Special coverage instructions apply
BETOS Type of Service
Other drugs
Medicare Payment Limit
$1.64
Medicare Co-Insurance Percentage
20.000%
HCPCS Classification
List of HCPCS codes for: Drugs Administered Other Than Oral Method, Chemotherapy Drugs (J-codes)

HCPCS Crossover to NDC Codes

The NDC codes below allow precise billing based on the specific manufacturer and medication used:

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0409-5082Tazicef CeftazidimeInjection, Powder, For SolutionIntramuscular; IntravenousHospira, Inc.ACTIVE
0409-5082Tazicef Hospira, Inc.
0409-5084Tazicef CeftazidimeInjection, Powder, For SolutionIntravenousHospira, Inc.ACTIVE
0409-5084Tazicef Hospira, Inc.
0409-5086Tazicef CeftazidimeInjection, Powder, For SolutionIntravenousHospira, Inc.ACTIVE
0409-5092Tazicef CeftazidimeInjection, Powder, For SolutionIntravenousHospira, Inc.ACTIVE
0409-5093Tazicef CeftazidimeInjection, Powder, For SolutionIntravenousHospira, Inc.ACTIVE
0781-3177Ceftazidime Sandoz Inc
0781-3178Ceftazidime Sandoz Inc
0781-3179Ceftazidime Sandoz Inc
25021-127Ceftazidime CeftazidimeInjection, Powder, For SolutionIntramuscular; IntravenousSagent PharmaceuticalsACTIVE
25021-127Ceftazidime Sagent Pharmaceuticals
25021-128Ceftazidime CeftazidimeInjection, Powder, For SolutionIntravenousSagent PharmaceuticalsACTIVE
25021-128Ceftazidime Sagent Pharmaceuticals
25021-129Ceftazidime CeftazidimeInjection, Powder, For SolutionIntravenousSagent PharmaceuticalsACTIVE
25021-129Ceftazidime Sagent Pharmaceuticals
44567-235Ceftazidime CeftazidimeInjection, Powder, For SolutionIntramuscular; IntravenousWg Critical Care, LlcACTIVE
44567-236Ceftazidime CeftazidimeInjection, Powder, For SolutionIntravenousWg Critical Care, LlcACTIVE
44567-237Ceftazidime CeftazidimeInjection, Powder, For SolutionIntravenousWg Critical Care, LlcACTIVE
52565-105Fortaz Teligent Pharma, Inc.INACTIVATED
52565-106Fortaz Teligent Pharma, Inc.INACTIVATED
52565-107Fortaz Teligent Pharma, Inc.INACTIVATED